NPM Capital has supported the management buy out of Rotterdam, the Netherlands-based Shield Group Nederland from ABN AMRO Participaties.
The company inspects, analyses and monitors hazardous substances such as Legionella pneumophila and asbestos in the Netherlands, Belgium and Spain. Shield, which currently has 140 employees, operates in the three countries through Fibrecount, Bioconsult and Oesterbaai.
The investment, which will be effected early September, after a few issues, including the consent of the Netherlands Competition Authority NMa, aims to help Shield further develop the business.
FinSMEs
14/07/2011